VEEVA SYSTEMS INC CLASS A

NYSE: VEEV (Veeva Systems Inc.)

Last update: 09 Apr, 7:07AM

209.39

-5.35 (-2.49%)

Previous Close 214.74
Open 220.45
Volume 1,110,886
Avg. Volume (3M) 1,228,516
Market Cap 34,066,915,328
Price / Earnings (TTM) 48.58
Price / Earnings (Forward) 32.36
Price / Sales 14.23
Price / Book 6.60
52 Weeks Range
170.25 (-18%) — 258.93 (23%)
Earnings Date 28 May 2025 - 2 Jun 2025
Profit Margin 26.00%
Operating Margin (TTM) 26.14%
Diluted EPS (TTM) 4.33
Quarterly Revenue Growth (YOY) 14.30%
Quarterly Earnings Growth (YOY) 32.70%
Total Debt/Equity (MRQ) 1.30%
Current Ratio (MRQ) 4.51
Operating Cash Flow (TTM) 1.09 B
Levered Free Cash Flow (TTM) 942.78 M
Return on Assets (TTM) 6.57%
Return on Equity (TTM) 13.63%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bearish Mixed
Health Information Services (Global) Bearish Mixed
Stock Veeva Systems Inc. Bullish Bullish

AIStockmoo Score

1.8
Analyst Consensus 1.5
Insider Activity NA
Price Volatility 1.0
Technical Moving Averages 2.5
Technical Oscillators 2.0
Average 1.75

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
VEEV 34 B - 48.58 6.60
SOLV 12 B - 23.94 3.74
DOCS 11 B - 59.47 10.35
PHR 1 B - - 5.41
EVH 1 B - - 1.15
WEAV 708 M - - 9.97

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Sector Healthcare
Industry Health Information Services
Investment Style Mid Growth
% Held by Insiders 8.90%
% Held by Institutions 84.42%
52 Weeks Range
170.25 (-18%) — 258.93 (23%)
Price Target Range
201.00 (-4%) — 285.00 (36%)
High 285.00 (Baird, 36.11%) Buy
Median 250.00 (19.39%)
Low 201.00 (Morgan Stanley, -4.01%) Sell
Average 250.22 (19.50%)
Total 5 Buy, 3 Hold, 1 Sell
Avg. Price @ Call 232.65
Firm Date Target Price Call Price @ Call
Piper Sandler 23 Apr 2025 255.00 (21.78%) Buy 220.53
Keybanc 16 Apr 2025 250.00 (19.39%) Buy 220.66
JP Morgan 20 Mar 2025 249.00 (18.92%) Hold 235.85
Baird 06 Mar 2025 285.00 (36.11%) Buy 236.14
Morgan Stanley 06 Mar 2025 201.00 (-4.01%) Sell 236.14
Needham 06 Mar 2025 270.00 (28.95%) Buy 236.14
Scotiabank 06 Mar 2025 245.00 (17.01%) Hold 236.14
Stephens & Co. 06 Mar 2025 280.00 (33.72%) Buy 236.14
Truist Securities 06 Mar 2025 217.00 (3.63%) Hold 236.14

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria